... involved in the lack of responseto oxaliplatin in monotherapy or combined with cetuximab.Background The incidence of colorectal cancer has been increasing in the last few years, while the age of ... [1]. The advances in the treatment of this disease include studies of single-agen ts vs. combination treatment with 5-FU/leucovorin,irinotecan, oxal iplatin, and capecitabine, and the role of targeted ... oxaliplatin in monotherapyor oxaliplatin plus cetuximab. In comparison, in SW-480 and Caco-2 cells treatedwith oxaliplatin in monotherap y or i n combination withcetuximab, increasing mRNA...